Is Editas Medicine, Inc. overvalued?

Editas Medicine, Inc. (EDIT) — key valuation metrics and fundamentals.

No verdict

Price

$2.51

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$385.2M

Dividend yield

0.0%

Return on equity

-196.6%

Sector

Healthcare

Fair value compares EDIT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 27 Sep 2026.

Related stocks